TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 3 | 3 | 4 | 6 | 29 | 1 | 7 |
| P | %wins | 100 | 100 | 50 | 50 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/17 10:24 | 11/15/17 | CRIS | Curis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fattaey Ali Ph.D. | MA | DO | P,CEO | P | 53 | 1.06 | 0 | 50 | 76 | 116 | D | ||||||||||||||
8/28/14 09:53 | 8/27/14 | CRIS | Curis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fattaey Ali Ph.D. | MA | DO | P,CEO | P | 101 | 1.60 | 2 | 63 | 999% | 66 | D | -60 | -61 | -50 | -15 | -6 | -12 | -4 | 0 | 6 | 4 | -12 | -10 | 94 | 57 |
12/12/13 16:02 | 12/11/13 | CRIS | Curis Inc | DE | Health | BioPrd | Biological Products, (No Diag | Fattaey Ali Ph.D. | MA | O | P,COO | P | 8 | 2.52 | 2 | 3 | New | 3 | D | -31 | -27 | -31 | -42 | -39 | -10 | -23 | -28 | 0 | 1 | 19 | 21 | -37 | -56 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |